Overview
Corporate Profile
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with cancer and other serious diseases. We harness our NAM-enabled technology platform to create therapies with the potential to improve the course of cancer care.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Latest News
View All
May 31, 2023
Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference
Read More
May 31, 2023
Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting
Read More
May 15, 2023
Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update
Read More
May 11, 2023
Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast
Read More
Apr 17, 2023
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
Read More
Mar 27, 2023
Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update
Read More
Mar 20, 2023
Gamida Cell Announces the Date of Its Fourth Quarter and Full Year 2022 Financial Results and Webcast
Read More
Mar 07, 2023
Gamida Cell to Present Corporate Highlights at the Oppenheimer 33rd Annual Healthcare Conference
Read More
Feb 18, 2023
Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTR
Read More
Nov 23, 2022
Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences
Read More
Nov 14, 2022
Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update
Read More
Nov 10, 2022
Gamida Cell to Present Corporate Highlights at the Jefferies London Healthcare Conference
Read More
Nov 07, 2022
Gamida Cell Announces the Date of Its Third Quarter 2022 Financial Results and Webcast
Read More
Nov 07, 2022
GDA-501, NAM enabled NK Cell Therapy, Demonstrates Promising Antitumor Activity Against HER2+ Cancers
Read More
Upcoming Events
Recent Events
May 19, 2023 at 10:00 AM EDT
Corporate Fact Sheet
More information is coming soon.
Corporate Presentation
More information is coming soon.
In the News
March 10, 2023
Source
Insightscare Magazine
February 7, 2023
Source
BioSpectrum
February 6, 2023
Source
Nasdaq
January 25, 2023
Source
Rare Disease Advisor
January 19, 2023
Source
Pharmaceutical Technology
December 29, 2022
Source
Globes
September 23, 2022
Source
BioSpace
September 5, 2022
Source
The Wall Street Transcript
August 16, 2022
Source
Cell & Gene Therapy Insights
December 1, 2021
Source
Life Science Leader
Investor & Media Contact
Ryan Pugliares
Gamida Cell Ltd.
IRPR@gamida-cell.com